Functional identification of three receptor activator of NF-κB cytoplasmic motifs mediating osteoclast differentiation and function

被引:43
作者
Liu, W
Xu, DR
Yang, HM
Xu, H
Shi, ZQ
Cao, XM
Takeshita, S
Liu, JZ
Teale, M
Feng, X
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Dermatol, Birmingham, AL 35294 USA
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Guangdong Prov, Peoples R China
[4] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M404687200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor activator of NF-kappaB ligand (RANKL) and its receptor activator of NF-kappaB (RANK) play pivotal roles in osteoclast differentiation and function. However, the structural determinants of the RANK that mediate osteoclast formation and function have not been definitively identified. To address this issue, we developed a chimeric receptor approach that permits a structure/function study of the RANK cytoplasmic domain in osteoclasts. Using this approach, we examined the role of six RANK putative tumor necrosis factor receptor-associated factor-binding motifs (PTM) (PTM1, ILLMT-REE286-293; PTM2, PSQPS(349-353); PTM3, PFQEP(369-373); PTM4, VYVSQTSQE(537-545); PTM5, PVQEET(559-564); and PTM6, PVQEQG(604-609)) in osteoclast formation and function. Our data revealed that the RANK cytoplasmic domain possesses three functional motifs (PFQEP(369-373), PVQEET(559-564), and PVQEQG(604-609)) capable of mediating osteoclast formation and function. Moreover, we demonstrated that these motifs play distinct roles in activating intracellular signaling. PFQEP(369-373) initiates NF-kappaB, c-Jun N-terminal kinase, extracellular signal-regulated kinase, and p38 signaling pathways and PVQEET(559-564) activates NF-kappaB and p38 pathways in osteoclasts, whereas PVQEQG(604-609) is only capable of activating NF-kappaB pathway. Significantly, the revelation of these functional RANK cytoplasmic motifs has not only laid a foundation for further delineating RANK signaling pathways in osteoclasts, but, more importantly, these RANK motifs themselves represent potential therapeutic targets for bone disorders such as osteoporosis.
引用
收藏
页码:54759 / 54769
页数:11
相关论文
共 41 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]   Lymphocyte survival - The struggle against death [J].
Arch, RH ;
Thompson, CB .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :113-140
[3]   A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function [J].
Armstrong, AP ;
Tometsko, ME ;
Glaccum, M ;
Sutherland, CL ;
Cosman, D ;
Dougall, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44347-44356
[4]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[5]   The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[6]  
Darnay BG, 1999, ANN RHEUM DIS, V58, P2
[7]   Characterization of the intracellular domain of receptor activator of NF-κB (RANK) -: Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase [J].
Darnay, BG ;
Haridas, V ;
Ni, J ;
Moore, PA ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20551-20555
[8]   Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase -: Identification of a novel TRAF6 interaction motif [J].
Darnay, BG ;
Ni, J ;
Moore, PA ;
Aggarwal, BB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7724-7731
[9]   Present and future pharmacotherapy for osteoporosis [J].
Doggrell, SA .
DRUGS OF TODAY, 2003, 39 (08) :633-657
[10]   RANK is essential for osteoclast and lymph node development [J].
Dougall, WC ;
Glaccum, M ;
Charrier, K ;
Rohrbach, K ;
Brasel, K ;
De Smedt, T ;
Daro, E ;
Smith, J ;
Tometsko, ME ;
Maliszewski, CR ;
Armstrong, A ;
Shen, V ;
Bain, S ;
Cosman, D ;
Anderson, D ;
Morrissey, PJ ;
Peschon, JJ ;
Schuh, J .
GENES & DEVELOPMENT, 1999, 13 (18) :2412-2424